Related Experiment Video
Updated: Jun 21, 2026
10:32
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Published on: June 5, 2015
[Regenerative medicine for anti-aging].
Katsumi Ebisawa1, Hideaki Kagami, Ryuji Kato
1Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 14, 2009
Summary
Regenerative medicine, focusing on tissue repair, offers anti-aging benefits. Clinical applications include fibroblast, stem cell, and PRP therapies, with ongoing research into dermal papilla cells for rejuvenation.
Area of Science:
- Regenerative medicine
- Tissue engineering
- Anti-aging therapies
Context:
- Regenerative medicine aims to restore damaged tissues using cells, chemical substances, and scaffolds.
- Rejuvenation is a key purpose of regenerative medicine, aligning it with anti-aging strategies.
- While embryonic stem cells (ES) and induced pluripotent stem cells (iPS) show promise, they are not yet in clinical use.
Purpose:
- To explore the intersection of regenerative medicine and anti-aging treatments.
- To highlight clinically applied regenerative medicine techniques for rejuvenation.
- To discuss ongoing research in regenerative approaches for anti-aging.
Summary:
- Clinically successful regenerative medicine applications for anti-aging include cultured fibroblasts, adipose tissue-derived stem cells, and platelet-rich plasma (PRP).
- Research continues into cultured dermal papilla cells as a regenerative approach for anti-aging.
- These methods leverage the body's natural healing processes for tissue restoration and rejuvenation.
Impact:
- Provides insights into current clinical applications of regenerative medicine for anti-aging.
- Identifies promising areas for future research in rejuvenation therapies.
- Facilitates understanding of the practical use of regenerative medicine beyond theoretical stem cell applications.
More Related Videos
Related Concept Videos
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...